- Free current stock price quotes and data for 22nd Century Group Inc (XXII). Research news, charts, stock market performance and earnings. ... (XXII) said Thursday that it has named R. Hugh Kinsman as its chief financial officer. Kinsman is CFO of GVB Biopharma, which was...--Craig-Hallum Starts 22nd Century Group at Buy With $5 Price Target
- CFO of GVB Biopharma to Expand Role, Become CFO of 22nd Century Group; Integration of GVB Biopharma Proceeding at a Rapid Pace ; BUFFALO, N.Y., June 16, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company), dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today ...
- Shares of 22nd Century ( NASDAQ: XXII) rose 9.6% to $1.72 in Friday morning trade, after the biotech firm acquired privately held hemp/cannabis company GVB
- Jun-09-21 04:30PM. 22nd Century Announces Closing of $40 Million Common Stock Registered Direct Offering. GlobeNewswire. 01:35PM. Reduced Nicotine Tobacco and Cannabinoid Innovator 22nd Century Group to Be Added to Russell 2000®, Russell 3000®, and Russell Global Indexes. GlobeNewswire.
- The article read, "In fact, the stock (XXII) has a realistic chance of multiplying by 10 times over the coming years if the limit is imposed. ... GVB Biopharma is now a 22nd Century company. 22nd ...